🇺🇸 Intermitent dosing as per SMPC in United States

Intermitent dosing as per SMPC (Intermitent dosing as per SMPC) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Intermitent dosing as per SMPC in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Intermitent dosing as per SMPC approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Intermitent dosing as per SMPC in United States?

Ivan Šitum, MD is the originator. The local marketing authorisation holder may differ — check the official source linked above.